167 related articles for article (PubMed ID: 19109820)
1. Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features.
Bruna J; González L; Miró J; Velasco R; Gil M; Tortosa A;
Cancer; 2009 Jan; 115(2):381-9. PubMed ID: 19109820
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features.
Palma JA; Fernandez-Torron R; Esteve-Belloch P; Fontes-Villalba A; Hernandez A; Fernandez-Hidalgo O; Gallego Perez-Larraya J; Martinez-Vila E
Clin Neurol Neurosurg; 2013 Jan; 115(1):19-25. PubMed ID: 22534095
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of leptomeningeal carcinomatosis in 4 cases].
Bao J; Hu XQ; Jiang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2047-9. PubMed ID: 19033125
[TBL] [Abstract][Full Text] [Related]
4. Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology.
Chamberlain MC; Johnston SK
Cancer; 2009 May; 115(9):1941-6. PubMed ID: 19235827
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of leptomeningeal carcinomatosis from gastric cancer].
Okuda T; Kataoka K; Kato A
Gan To Kagaku Ryoho; 2009 Apr; 36(4):599-603. PubMed ID: 19381031
[TBL] [Abstract][Full Text] [Related]
6. Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis.
Torrejón D; Oliveira M; Cortes J; Sanchez-Olle G; Gómez P; Bellet M; Saura C; Peg V; Rovira A; Di Cosimo S
Breast; 2013 Feb; 22(1):19-23. PubMed ID: 23137566
[TBL] [Abstract][Full Text] [Related]
7. Treatment modalities for leptomeningeal metastases.
Shapiro WR; Johanson CE; Boogerd W
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S46-54. PubMed ID: 19660683
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.
Chamberlain MC; Johnston SK; Glantz MJ
Arch Neurol; 2009 Jan; 66(1):74-8. PubMed ID: 19139302
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and prognostic factors in patients with leptomeningeal metastases].
Li N; Yang BY; Li JL; Zhu JQ; Zou BH; Wang YF; Yu L; Yao XY
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):867-70. PubMed ID: 24447488
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer.
Lara-Medina F; Crismatt A; Villarreal-Garza C; Alvarado-Miranda A; Flores-Hernández L; González-Pinedo M; Gamboa-Vignolle C; Ruiz-González JD; Arrieta O
Breast J; 2012; 18(3):233-41. PubMed ID: 22487060
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis.
Subirá D; Simó M; Illán J; Serrano C; Castañón S; Gonzalo R; Granizo JJ; Martínez-García M; Navarro M; Pardo J; Bruna J
Clin Exp Metastasis; 2015 Apr; 32(4):383-91. PubMed ID: 25795393
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid cytology and clinical analysis of 34 cases with leptomeningeal carcinomatosis.
Liu J; Jia H; Yang Y; Dai W; Su X; Zhao G
J Int Med Res; 2009; 37(6):1913-20. PubMed ID: 20146891
[TBL] [Abstract][Full Text] [Related]
15. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis.
Cho HR; Wen H; Ryu YJ; An YJ; Kim HC; Moon WK; Han MH; Park S; Choi SH
Cancer Res; 2012 Oct; 72(20):5179-87. PubMed ID: 22926555
[TBL] [Abstract][Full Text] [Related]
16. A novel method for administering intrathecal chemotherapy in patients with leptomeningeal metastases and shunted hydrocephalus: case report.
Zada G; Chen TC
Neurosurgery; 2010 Sep; 67(3 Suppl Operative):onsE306-7; discussion onsE307. PubMed ID: 20679917
[TBL] [Abstract][Full Text] [Related]
17. Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
Breccia M; Frustaci AM; Cannella L; Stefanizzi C; Latagliata R; Cartoni C; Diverio D; Guarini A; Nanni M; Rago A; Cimino G; Alimena G
Hematol Oncol; 2009 Sep; 27(3):148-53. PubMed ID: 19274612
[TBL] [Abstract][Full Text] [Related]
18. Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis.
Harter P; Hahmann M; Lueck HJ; Poelcher M; Wimberger P; Ortmann O; Canzler U; Richter B; Wagner U; Hasenburg A; Burges A; Loibl S; Meier W; Huober J; Fink D; Schroeder W; Muenstedt K; Schmalfeldt B; Emons G; du Bois A
Ann Surg Oncol; 2009 May; 16(5):1324-30. PubMed ID: 19225844
[TBL] [Abstract][Full Text] [Related]
19. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.
An YJ; Cho HR; Kim TM; Keam B; Kim JW; Wen H; Park CK; Lee SH; Im SA; Kim JE; Choi SH; Park S
Int J Cancer; 2015 Jan; 136(1):162-71. PubMed ID: 24798643
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
